radiolabeled SPD557

Radiolabeled SPD557 is a version of the investigational drug SPD557 that has been tagged with a radioactive isotope (likely carbon-14) for use in human absorption, metabolism, and excretion (AME) studies. The purpose of radiolabeling is to track the pharmacokinetics and metabolic fate of the compound in healthy volunteers. The study referenced was conducted by Shire to evaluate how a single dose of radiolabeled SPD557 is absorbed, metabolized, and excreted in male volunteers. There are no publicly available details on the precise mechanism of action or therapeutic indication for non-radiolabeled SPD557; this formulation appears to be used exclusively for clinical pharmacology research[2].